Sale Completion

RNS Number : 6502V
Yule Catto & Co PLC
30 May 2008
 





Yule Catto & Co. plc


Completion of James Robinson sale




Yule Catto is an international producer of speciality chemicals, supplied to global customers for use in a wide range of industries including pharmaceuticals, FMCG, paints and adhesives


Further to the announcement on 11 February 2008, Yule Catto & Co plc ('Yule Catto') is pleased to announce that sale of the entire issued share capital of James Robinson Limited and other associated assets to Vivimed Labs Limited has been successfully completed for a total consideration, including the realisation of working capital, of up to US$25 million.


In addition, Yule Catto anticipates that the sale of its interest in James Robinson India (Private) Limited to its joint venture partner for a consideration of some $1.75 million will take place in June.


Adrian Whitfield, Chief Executive, comments:


'This sale marks another stage in Yule Catto's corporate strategy of realising improved shareholder value from its Impact Chemicals activities.'


30 May 2008




ENQUIRIES:

 

YULE CATTO

Tel: 01279 442791

Adrian Whitfield, Chief Executive 

 

David Blackwood, Finance Director

 

COLLEGE HILL 

Tel: 020 7457 2020 

Gareth David

 








This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MERUROORWNRVOAR

Companies

Synthomer (SYNT)
UK 100

Latest directors dealings